X-53413144-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006306.4(SMC1A):c.616-6G>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000246 in 1,210,012 control chromosomes in the GnomAD database, including 2 homozygotes. There are 167 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006306.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMC1A | NM_006306.4 | c.616-6G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000322213.9 | NP_006297.2 | |||
SMC1A | NM_001281463.1 | c.550-6G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001268392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMC1A | ENST00000322213.9 | c.616-6G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_006306.4 | ENSP00000323421 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000116 AC: 13AN: 111840Hom.: 0 Cov.: 23 AF XY: 0.000206 AC XY: 7AN XY: 34008
GnomAD3 exomes AF: 0.000478 AC: 87AN: 181875Hom.: 0 AF XY: 0.000670 AC XY: 45AN XY: 67161
GnomAD4 exome AF: 0.000260 AC: 285AN: 1098117Hom.: 2 Cov.: 32 AF XY: 0.000440 AC XY: 160AN XY: 363475
GnomAD4 genome AF: 0.000116 AC: 13AN: 111895Hom.: 0 Cov.: 23 AF XY: 0.000205 AC XY: 7AN XY: 34073
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Congenital muscular hypertrophy-cerebral syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Congenital muscular hypertrophy-cerebral syndrome;C5393312:Developmental and epileptic encephalopathy, 85, with or without midline brain defects Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 23, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at